Life Stem Genetics, American CryoStem Announce Collaboration

Life Stem Genetics LIFS announced today a strategic collaborative agreement with American CryoStem Corporation, CRYO. CRYO is a leading developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries. Adipose tissue is an anatomical term for loose connective tissue (fat) composed of adipocytes (cells). It is used in LIFS stem cell procedures and currently is extracted via liposuction each time a patient has a treatment. This collaboration will give our physician's network the ability to store a patient's adipose tissue for future regenerative medicine applications after only one extraction process. In the absence of future liposuction procedures, the patient's recovery time is See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!